Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

SciSparc Ltd Secures 20 Million Standby Equity Purchase Agreement with YA II PN Ltd for Accelerated Growth and Expansion

Elaine Mendonca by Elaine Mendonca
January 24, 2024
in Breaking News
0
Finance_ projections
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

On January 24, 2024, SciSparc Ltd. announced a significant milestone in its growth strategy by entering into a standby equity purchase agreement (SEPA) with YA II PN, Ltd., a renowned fund managed by Yorkville Advisors Global, LP. This agreement marks a pivotal moment for SciSparc Ltd. as it secures a commitment from YA to purchase up to $20 million worth of the company’s ordinary shares over the next thirty-six months.

To ensure a fair and mutually beneficial arrangement, the agreement includes a beneficial ownership cap of 4.99% of the share capital of the company. This safeguard ensures that both parties maintain a balanced stake in the company’s future.

Under the terms of the agreement, the purchase price of the ordinary shares will be set at a 3% discount of the weighted average price of the company’s ordinary shares. This calculation will be based on the three consecutive trading day period commencing on the trading day when the company delivers an advance notice to YA.

This strategic partnership between SciSparc Ltd. and YA II PN, Ltd. sets the stage for accelerated growth and expansion opportunities. By securing this standby equity purchase agreement, SciSparc Ltd. gains access to vital capital that will fuel its ongoing research and development initiatives, as well as support its market penetration efforts.

The agreement not only showcases the confidence that YA II PN, Ltd. has in SciSparc Ltd.’s potential but also highlights the company’s commitment to maximizing shareholder value. As SciSparc Ltd. continues to make strides in the pharmaceutical industry, this partnership will undoubtedly contribute to its long-term success.

SPRC Stock Price Shows Positive Momentum with Modest Increase and Pre-Market Surge

On January 24, 2024, SPRC stock showcased some interesting price movements. The price of SPRC shares witnessed a modest increase of $0.07 since the market last closed, representing a rise of 2.06%. The closing price for SPRC on the previous day was $3.46, and with this increase, it reached $3.53. In pre-market trading, the stock continued to surge, with a further increase of $2.91. The pre-market price of SPRC reached $6.44, significantly higher than the closing price of the previous day. While these price movements are positive, it is important to note that the stock was trading near the bottom of its 52-week range and below its 200-day simple moving average. Investors should approach these recent price movements with caution and consider the stock’s overall performance and market conditions. It is worth mentioning that stock prices can be influenced by various factors, including market sentiment, company news, industry trends, and economic indicators. Therefore, it is crucial for investors to conduct thorough research and analysis before making any investment decisions. Overall, the price momentum of SPRC on January 24, 2024, showed some positive signs with a modest increase since the previous day’s close and a significant surge in pre-market trading. However, investors should consider the stock’s overall performance and market conditions before making any investment decisions.

Unavailability of Financial Data Impacts SPRC Stock Performance on January 24, 2024

Title: SPRC Stock Performance on January 24, 2024: A Closer Look at the Data

Introduction:
On January 24, 2024, SPRC stock experienced a day of trading with limited information available regarding the company’s financials. In this article, we will explore the implications of this information gap and discuss the potential impact on SPRC’s stock performance.

Limited Financial Information:
Unfortunately, on January 24, 2024, CNN Money reported that SPRC’s total revenue, net income, and earnings per share were temporarily unavailable. This lack of financial data can be concerning for investors, as it impedes their ability to assess the company’s financial health and make informed investment decisions.

Investor Reaction:
The absence of financial information can trigger uncertainty and caution among investors. Without a clear understanding of SPRC’s financial performance, investors may hesitate to buy or sell the stock, leading to reduced trading volume and potentially impacting the stock’s price stability.

Market Volatility:
In the absence of concrete financial data, stock prices can become more susceptible to market volatility. The absence of key metrics can lead to increased speculation and uncertainty, resulting in heightened price fluctuations. Consequently, SPRC’s stock price may experience increased volatility until the missing financial data is made available.

Implications for SPRC:
The unavailability of financial information for SPRC on January 24, 2024, raises concerns about the company’s transparency and governance practices. The absence of this information can create a sense of unease and may lead to a loss of investor confidence.

Conclusion:
SPRC’s stock performance on January 24, 2024, was impacted by the unavailability of crucial financial information. It is crucial for SPRC to promptly address this issue and provide the necessary financial data to restore investor confidence and stability in the market.

Tags: SPRC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Johnson Johnson Reports Strong Financial Results and Addresses Concerns

Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

Cytokinetics Receives Revised Rating from UBS Analyst Downgraded to Neutral with Raised Price Target

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com